Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination

Detalles Bibliográficos
Autores principales: Blixt, Lisa, Gao, Yu, Wullimann, David, Murén Ingelman-Sundberg, Hanna, Muschiol, Sandra, Healy, Katie, Bogdanovic, Gordana, Pin, Elisa, Nilsson, Peter, Kjellander, Christian, Grifoni, Alba, Sette, Alessandro, Sällberg Chen, Margaret, Ljunggren, Hans-Gustaf, Buggert, Marcus, Hansson, Lotta, Österborg, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Letter to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512527/
https://www.ncbi.nlm.nih.gov/pubmed/36150168
http://dx.doi.org/10.1182/blood.2022016815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512527/
https://www.ncbi.nlm.nih.gov/pubmed/36150168
http://dx.doi.org/10.1182/blood.2022016815

Ejemplares similares